Under the agreement, APIs manufactured by Indoco will be marketed and sold by DSM.
The APIs are used to produce pharmaceutical Finished Dosages.
The alliance will employ Indoco’s product development and cGMP (current Good Manufacturing Practices) compliant manufacturing capabilities and DSM’s market access.
Indoco Remedies is a global pharmaceutical company with a brand portfolio of 120 products in various therapeutic segments, including anti-infectives, anti-diabetics, cardiovascular, ophthalmology, dental care, pain management and respiratory.
DSM Pharmaceutical Products, a business group of Royal DSM, is a global science-based company active in health, nutrition and materials.